Mogamulizumab-kpkc Intravenous and OxyIR
Determining the interaction of Mogamulizumab-kpkc Intravenous and OxyIR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: oxycodone
Brand name: OxyIR, Roxicodone, Roxybond, Oxaydo, Oxycontin, Oxyfast, Xtampza ER, Oxecta, Oxycontin, Roxybond, Xtampza ER; oxycodone is also present in the following combination drugs: Combunox, Endocet, Endodan, Moxduo, Oxycodan, Percocet, Percodan, Primlev, Roxicet, Xartemis XR, and others
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Oxymetazoline Hydrochloride
- Mogamulizumab-kpkc Intravenous-Oxymetazoline Hydrochloride topical
- Mogamulizumab-kpkc Intravenous-Oxymetazoline nasal
- Mogamulizumab-kpkc Intravenous-Oxymetazoline ophthalmic
- Mogamulizumab-kpkc Intravenous-Oxymetazoline topical
- Mogamulizumab-kpkc Intravenous-Oxymetazoline Topical application
- OxyIR-Molindone
- OxyIR-Mometasone (Oral Inhalation)
- OxyIR-Mometasone and Formoterol
- OxyIR-Mometasone and formoterol Inhalation
- OxyIR-Mometasone Cream
- OxyIR-Mometasone Furoate